All in a Day&#x27;s Lab Work

May 9th 2025

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

The investigational mRNA-1083 vaccine induced superior immune responses against all 4 flu strains in adults aged 50-64 years and against 3 in adults 65 and older.

May 7th 2025

Single Afternoon Dose of ICS Linked to Better Lung Function and Reduced Inflammation in Asthma

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

The chronotherapeutic approach aligns treatment with peak glucocorticoid sensitivity, so may mitigate onset of the inflammatory cascade that triggers nocturnal exacerbations.

Linda Stein Gold, MD;Sydney Jennings

March 9th 2025

FDA Greenlights Low-Dose Clorthalidone (12.5 mg) for Treatment of Hypertension in Adults

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Luke Halpern

GLP-1 Agonists May Preserve Muscle Mass During Weight Loss: Daily Dose

Low-dose clorthalidone offers clinicians a new option for initiating treatment that may mitigate well-known metabolic adverse effects.

Immunogenicity of Combined Flu/COVID-19 Vaccine Noninferior to Components in Older Adults

Your daily dose of the clinical news you may have missed.

Related Content

May 9th 2025

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

The investigational mRNA-1083 vaccine induced superior immune responses against all 4 flu strains in adults aged 50-64 years and against 3 in adults 65 and older.

May 7th 2025

Single Afternoon Dose of ICS Linked to Better Lung Function and Reduced Inflammation in Asthma

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD: Primary Viewpoints Podcast

The chronotherapeutic approach aligns treatment with peak glucocorticoid sensitivity, so may mitigate onset of the inflammatory cascade that triggers nocturnal exacerbations.

Linda Stein Gold, MD;Sydney Jennings

March 9th 2025

FDA Greenlights Low-Dose Clorthalidone (12.5 mg) for Treatment of Hypertension in Adults

“I think it’s important to have a lot of tools in our toolbox, and [tapinarof cream 1%] is one that gives us great flexibility," said Linda Stein Gold, MD.

Luke Halpern

GLP-1 Agonists May Preserve Muscle Mass During Weight Loss: Daily Dose

Low-dose clorthalidone offers clinicians a new option for initiating treatment that may mitigate well-known metabolic adverse effects.